Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Analog Devices Director Ray Stata Sells Shares Over Two Days

A Form 4 filed with the SEC on September 10, 2026 discloses that Ray Stata, a director of Analog Devices Inc (NASDAQ:ADI), sold a total of 2,632 shares of common stock across eleven transactions on September 8 and September 9, 2026, pursuant to a …

Vinay Lochav | 10 September 2026

Realty Income Director Sells 3,475 Shares via Trust

A Form 4 filed on September 10, 2026, reports that Gregory McLaughlin, a director of Realty Income Corp (NYSE:O), sold 3,475 shares of common stock held indirectly through a family trust on September 10, 2026.

Shwetambri Chauhan | 10 September 2026

Remitly Global Director Sells 11,000 Shares Over Two Days

A Form 4 filed on September 10, 2026 discloses that Joshua Hug, a director of Remitly Global, Inc. (NASDAQ:RELY), sold a total of 11,000 shares of common stock on September 8 and September 9, 2026, under a pre-established Rule 10b5-1 trading plan.

Aditi Sarkar | 10 September 2026

Cerebras Systems Director Reports Share Distribution

A statement of changes in beneficial ownership for Eric Vishria, a director at Cerebras Systems Inc., was filed with the SEC on September 10, 2026, disclosing a transaction dated September 8, 2026.

Nitish Kishor | 10 September 2026

Tapestry Chief People Officer Files Ownership Change

Denise Kulikowsky, Chief People Officer of Tapestry, Inc., filed a Form 4 with the SEC on September 10, 2026, reporting a series of transactions in Tapestry common stock dated September 9, 2026, including a stock option exercise and subsequent share disposals.

Shwetambri Chauhan | 10 September 2026

Century Therapeutics Director Receives 148,000 Stock Options

A Form 4 filed on September 10, 2026 with the U.S. Securities and Exchange Commission disclosed that Joseph Truitt, a newly appointed director of Century Therapeutics, Inc. (NASDAQ:IPSC), was granted 148,000 stock options on September 9, 2026 in connection with his appointment to the …

Anjali Anand | 10 September 2026

Recursion Pharmaceuticals CEO Sells 22,408 Shares

A Form 4 filed on September 8, 2026 with the SEC reports that Najat Khan, CEO and President of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), disposed of 22,408 shares of Class A Common Stock on September 8, 2026 under a pre-established Rule 10b5-1 trading plan.

Shwetambri Chauhan | 10 September 2026

Elastic N.V. Chief Legal Officer Sells Shares for Tax Withholding

Carolyn Herzog, Chief Legal Officer of Elastic N.V. (NASDAQ:ESTC), filed a Form 4 on September 10, 2026, reporting the sale of ordinary shares on September 9, 2026, to cover tax obligations arising from vesting equity awards.

Aditi Sarkar | 10 September 2026

Elastic N.V. Executive Sells Shares for Tax Withholding

Jane E. Bone, Group Vice President and Chief Accounting Officer of Elastic N.V., filed a Form 4 on September 10, 2026, reporting the sale of ordinary shares on September 9, 2026, to satisfy tax obligations connected to restricted stock unit vesting.

Vinay Lochav | 10 September 2026

Elastic N.V. CEO Sells 29,227 Shares in Tax Withholding Transaction

Ashutosh Kulkarni, Chief Executive Officer and Director of Elastic N.V., filed a Form 4 on September 10, 2026, reporting the sale of 29,227 ordinary shares on September 9, 2026, to satisfy tax obligations connected to vesting equity awards.

Nitish Kishor | 10 September 2026
Support

Hi! How can we help you today?

Loading…